We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Dow Chemical Seeks U.S. High Court Review On Patents Under Teva

(April 28, 2016, 1:41 PM EDT) -- WASHINGTON, D.C. — Two chemical companies argue to the U.S. Supreme Court in an April 15 brief that an appellate court properly considered Teva Pharmaceuticals USA, Inc. v. Sandoz, Inc. (135...
To view the full article, register now.